439 related articles for article (PubMed ID: 21057059)
1. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
Motawaj M; Burban A; Davenas E; Arrang JM
J Pharmacol Exp Ther; 2011 Feb; 336(2):479-87. PubMed ID: 21057059
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
4. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
5. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
6. Histamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site.
Burban A; Faucard R; Armand V; Bayard C; Vorobjev V; Arrang JM
J Pharmacol Exp Ther; 2010 Mar; 332(3):912-21. PubMed ID: 20008958
[TBL] [Abstract][Full Text] [Related]
7. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane.
Zoladz PR; Campbell AM; Park CR; Schaefer D; Danysz W; Diamond DM
Pharmacol Biochem Behav; 2006 Oct; 85(2):298-306. PubMed ID: 17045636
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
10. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
[TBL] [Abstract][Full Text] [Related]
11. Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Giorgetti M; Gibbons JA; Bernales S; Alfaro IE; Drieu La Rochelle C; Cremers T; Altar CA; Wronski R; Hutter-Paier B; Protter AA
J Pharmacol Exp Ther; 2010 Jun; 333(3):748-57. PubMed ID: 20194526
[TBL] [Abstract][Full Text] [Related]
12. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
Danysz W; Parsons CG
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
14. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine].
Kato T
Clin Calcium; 2004 Aug; 14(8):76-80. PubMed ID: 15577101
[TBL] [Abstract][Full Text] [Related]
15. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
16. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
18. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
[TBL] [Abstract][Full Text] [Related]
19. Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N-methyl-D-aspartate receptor channels in cultured rat hippocampal neurons.
Hirai T; Taniura H; Goto Y; Tamaki K; Oikawa H; Kambe Y; Ogura M; Ohno Y; Takarada T; Yoneda Y
J Neurosci Res; 2005 May; 80(4):491-500. PubMed ID: 15846781
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
